148 related articles for article (PubMed ID: 37051160)
1. Fibrosis-4 index, a predictor for prognosis of hepatocellular carcinoma patients after curative hepatectomy even in hepatitis B virus dominant populations.
Yun SO; Kim JM; Rhu J; Choi GS; Joh JW
Ann Surg Treat Res; 2023 Apr; 104(4):195-204. PubMed ID: 37051160
[TBL] [Abstract][Full Text] [Related]
2. The FIB-4 index is a significant prognostic factor in patients with non-B non-C hepatocellular carcinoma after curative surgery.
Okamura Y; Ashida R; Yamamoto Y; Ito T; Sugiura T; Bekku E; Aramaki T; Uesaka K
Langenbecks Arch Surg; 2016 Mar; 401(2):195-203. PubMed ID: 26943655
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma.
Xiao G; Zhu F; Wang M; Zhang H; Ye D; Yang J; Jiang L; Liu C; Yan L; Qin R
Dig Liver Dis; 2016 Oct; 48(10):1220-6. PubMed ID: 27599803
[TBL] [Abstract][Full Text] [Related]
4. The combination of the preoperative albumin-bilirubin grade and the fibrosis-4 index predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
Zhang J; Luo Y; Li C; Liu J; Xiang H; Wen T
Biosci Trends; 2019; 13(4):351-357. PubMed ID: 31527331
[TBL] [Abstract][Full Text] [Related]
5. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection.
Luo H; Li C; Chen L
Biosci Trends; 2019 May; 13(2):176-181. PubMed ID: 31061272
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of the FIB-4 index for non-B non-C hepatocellular carcinoma treated with surgical resection.
Nishikawa H; Osaki Y; Komekado H; Sakamoto A; Saito S; Nishijima N; Nasu A; Arimoto A; Kita R; Kimura T
Oncol Rep; 2015 Jan; 33(1):88-94. PubMed ID: 25354477
[TBL] [Abstract][Full Text] [Related]
7. A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort study.
Zhao Y; Kong LX; Feng FS; Yang J; Wei G
BMC Cancer; 2022 Mar; 22(1):311. PubMed ID: 35321670
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value and non-invasive predictors of splenomegaly in cirrhotic patients with hepatocellular carcinoma following curative resection.
Zhou L; Wang SB; Chen SG; Qu Q; Rui JA
Adv Clin Exp Med; 2020 Jul; 29(7):879-886. PubMed ID: 32745379
[TBL] [Abstract][Full Text] [Related]
9. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection.
Choi WM; Lee JH; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Lee YB; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS; Kim CY; Lee HS
Liver Int; 2015 Aug; 35(8):1992-2000. PubMed ID: 25556714
[TBL] [Abstract][Full Text] [Related]
10. ALBI/ST ratio versus FIB-4 and APRI as a predictor of posthepatectomy liver failure in hepatocellular carcinoma patients.
Zhang ZQ; Yang B; Zou H; Xiong L; Miao XY; Wen Y; Zhou JJ
Medicine (Baltimore); 2019 Apr; 98(15):e15168. PubMed ID: 30985698
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of noninvasive fibrosis indices for predicting hepatocellular carcinoma in treatment-naïve patients with chronic hepatitis B following entecavir therapy.
Jeong J; Shin JW; Jung SW; Lee SB; Park EJ; Park NH
Hepatol Res; 2021 Sep; 51(9):923-932. PubMed ID: 34224182
[TBL] [Abstract][Full Text] [Related]
12. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
[TBL] [Abstract][Full Text] [Related]
13. Comparison of non-invasive liver reserve and fibrosis models: Implications for surgery and prognosis for hepatocellular carcinoma.
Sonohara F; Yamada S; Tanaka N; Tashiro M; Sunagawa Y; Morimoto D; Tanaka H; Takami H; Hayashi M; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Kodera Y
Hepatol Res; 2019 Nov; 49(11):1305-1315. PubMed ID: 31260575
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
15. Clinical and novel application of FibroScan, FIB-4 and aspartate aminotransferase-to-platelet ratio index in liver fibrosis evaluation in patients with hepatocellular carcinoma and their roles in oesophageal variceal prediction.
Huang TH; Lin MT; Wang JH; Chang KC; Yen YH; Kuo FY; Huang CC; Hsiao CC; Chiu SY; Lu SN; Wang CC; Hu TH
Int J Clin Pract; 2021 Apr; 75(4):e13945. PubMed ID: 33338308
[TBL] [Abstract][Full Text] [Related]
16. Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.
Mao S; Yu X; Sun J; Yang Y; Shan Y; Sun J; Mugaanyi J; Fan R; Wu S; Lu C
BMC Cancer; 2022 Mar; 22(1):249. PubMed ID: 35255845
[TBL] [Abstract][Full Text] [Related]
17. Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients.
Li X; Xu H; Gao P
Med Sci Monit; 2019 Sep; 25():7243-7250. PubMed ID: 31558693
[TBL] [Abstract][Full Text] [Related]
18. Preoperative aspartate aminotransferase to platelet ratio is an independent prognostic factor for hepatitis B-induced hepatocellular carcinoma after hepatic resection.
Shen SL; Fu SJ; Chen B; Kuang M; Li SQ; Hua YP; Liang LJ; Guo P; Hao Y; Peng BG
Ann Surg Oncol; 2014 Nov; 21(12):3802-9. PubMed ID: 24849520
[TBL] [Abstract][Full Text] [Related]
19. Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma: a retrospective cohort study at two centers in China.
Liao R; Fu YP; Wang T; Deng ZG; Li DW; Fan J; Zhou J; Feng GS; Qiu SJ; Du CY
Oncotarget; 2017 Jan; 8(1):1774-1787. PubMed ID: 27662665
[TBL] [Abstract][Full Text] [Related]
20. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection.
Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A
Surgery; 2015 Apr; 157(4):699-707. PubMed ID: 25704421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
